BDBM50239229 CHEMBL4097255::US10676460, Example 1

SMILES C(Nc1nc(nc2cccc(-c3ccccc3)c12)-c1cncnc1)c1ccccn1

InChI Key InChIKey=UVJHJIXYGIZLLF-UHFFFAOYSA-N

Data  21 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 21 hits for monomerid = 50239229   

TargetTyrosine-protein kinase ITK/TSK(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetPotassium voltage-gated channel subfamily A member 5(Human)
Bristol-Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 90nMAssay Description:Inhibition of human Kv1.5 transfected in mouse LTK cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase TXK(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetAngiopoietin-1 receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase TBK1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group C member 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase Lyn(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase Lck(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 2.39E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetPotassium voltage-gated channel subfamily A member 5(Human)
Bristol-Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 90nMAssay Description:Inhibition of recombinant human Kv1.5 expressed in mouse L929 cells by patch clamp assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2019
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetCytoplasmic tyrosine-protein kinase BMX(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetInterleukin-1 receptor-associated kinase 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetInhibitor of nuclear factor kappa-B kinase subunit epsilon(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50239229(CHEMBL4097255 | US10676460, Example 1)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent